Alumis (NASDAQ:ALMS – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $25.00 price objective on the stock. HC Wainwright’s price objective suggests a potential downside of 11.50% from the company’s previous close. ALMS has […]

Precigen (NASDAQ:PGEN – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $14.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 123.29% from the company’s previous close. PGEN […]

HC Wainwright restated their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a research report released on Wednesday morning, MarketBeat Ratings reports. HC Wainwright currently has a $15.00 price objective on the stock. A number of other research analysts also recently commented on the stock. LADENBURG THALM/SH SH upped their […]

HC Wainwright restated their buy rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note released on Tuesday morning,Benzinga reports. They currently have a $140.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on the company. UBS Group boosted their price objective on Incyte […]